These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12955032)

  • 1. Measuring quality of life in patients with breast cancer: a systematic review of reliable and valid instruments available in Japan.
    Okamoto T; Shimozuma K; Katsumata N; Koike M; Hisashige A; Tanaka K; Ohsumi S; Saito M; Shikama N; Mitsumori M; Yamauchi C; Watanabe T;
    Breast Cancer; 2003; 10(3):204-13. PubMed ID: 12955032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia.
    Gadisa DA; Gebremariam ET; Ali GY
    Health Qual Life Outcomes; 2019 Dec; 17(1):182. PubMed ID: 31830992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients.
    Kontodimopoulos N; Ntinoulis K; Niakas D
    Eur J Cancer Care (Engl); 2011 May; 20(3):354-61. PubMed ID: 20345453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in women with breast cancer: a review of measures.
    Salas M; Mordin M; Castro C; Islam Z; Tu N; Hackshaw MD
    BMC Cancer; 2022 Jan; 22(1):66. PubMed ID: 35033009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients.
    Demirci S; Eser E; Ozsaran Z; Tankisi D; Aras AB; Ozaydemir G; Anacak Y
    Asian Pac J Cancer Prev; 2011; 12(5):1283-7. PubMed ID: 21875283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EORTC QLQ-BR23 and FACT-B for the assessment of quality of life in patients with breast cancer: a literature review.
    Nguyen J; Popovic M; Chow E; Cella D; Beaumont JL; Chu D; DiGiovanni J; Lam H; Pulenzas N; Bottomley A
    J Comp Eff Res; 2015 Mar; 4(2):157-66. PubMed ID: 25825844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validity and reliability of the quality of life questionnaire (EORTC QLQ C30) and its breast cancer module (EORTC QLQ BR23)].
    Zawisza K; Tobiasz-Adamczyk B; Nowak W; Kulig J; Jedrys J
    Ginekol Pol; 2010 Apr; 81(4):262-7. PubMed ID: 20476597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients.
    Apolone G; Filiberti A; Cifani S; Ruggiata R; Mosconi P
    Ann Oncol; 1998 May; 9(5):549-57. PubMed ID: 9653497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore.
    Chan A; Lew C; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
    Health Qual Life Outcomes; 2018 Jan; 16(1):20. PubMed ID: 29351803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
    Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
    J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Mexican-Spanish version of the EORTC QLQ-C30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancer.
    Cerezo O; Oñate-Ocaña LF; Arrieta-Joffe P; González-Lara F; García-Pasquel MJ; Bargalló-Rocha E; Vilar-Compte D
    Eur J Cancer Care (Engl); 2012 Sep; 21(5):684-91. PubMed ID: 22329843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Questionnaire to assess quality of life in patients with breast cancer - Validation of the Chinese version of the EORTC QLQ-BR 53.
    Zhang Z; Zhang X; Wei L; Lin Y; Wu D; Xie S; Yue L; Tian J; Zhang Y; Song Q; Woo SM; Miller AR; Luo L; Zhang L
    Breast; 2017 Apr; 32():87-92. PubMed ID: 28068605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
    Wallwiener M; Matthies L; Simoes E; Keilmann L; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Fasching PA; Lux MP; Wallwiener D; Taran FA; Rom J; Schneeweiss A; Graf J; Brucker SY
    J Med Internet Res; 2017 Sep; 19(9):e322. PubMed ID: 28912116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the EORTC STO-22 and the FACT-Ga quality of life questionnaires for patients with gastric cancer.
    Woo A; Fu T; Popovic M; Chow E; Cella D; Wong CS; Lam H; Pulenzas N; Lechner B; Vuong S; Ganesh V; Bottomley A
    Ann Palliat Med; 2016 Jan; 5(1):13-21. PubMed ID: 26841811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
    Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.
    Fitzsimmons D; Kahl S; Butturini G; van Wyk M; Bornman P; Bassi C; Malfertheiner P; George SL; Johnson CD
    Am J Gastroenterol; 2005 Apr; 100(4):918-26. PubMed ID: 15784041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of patient-reported outcome measures for advanced skin cancer patients.
    Reinhardt ME; Sun T; Pan CX; Schmults CD; Lee EH; Waldman AB
    Arch Dermatol Res; 2023 Aug; 315(6):1473-1480. PubMed ID: 36469125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer (EORTC) Breast-Cancer-Specific Quality of Life Questionnaire (EORTC QLQ-BR23).
    Yun YH; Bae SH; Kang IO; Shin KH; Lee R; Kwon SI; Park YS; Lee ES
    Support Care Cancer; 2004 Jun; 12(6):441-5. PubMed ID: 15088137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring quality of life in thai women with breast cancer.
    Glangkarn S; Promasatayaprot V; Porock D; Edgley A
    Asian Pac J Cancer Prev; 2011; 12(3):637-44. PubMed ID: 21627357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EORTC QLQ-C30 and FACT-Lym for the assessment of health-related quality of life of newly diagnosed lymphoma patients undergoing chemotherapy.
    Georgakopoulos A; Kontodimopoulos N; Chatziioannou S; Niakas D
    Eur J Oncol Nurs; 2013 Dec; 17(6):849-55. PubMed ID: 23850411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.